Jalyn Capsule
Product Images NDC 80725-809

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Jalyn (NDC 80725-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Jalyn 01)

Chemical structure diagram of the active ingredient Dutasteride, showing its molecular configuration with functional groups and atoms clearly depicted.*

FDA Label Image

Chemical Structure (Jalyn 02)

Chemical structure of Dutasteride and Tamsulosin Hydrochloride shown as a molecular diagram with various functional groups, rings, and bonds consistent with the combined active ingredients in Jalyn capsules.*

FDA Label Image

Figure 1 (Jalyn 03)

A line graph depicting mean changes from baseline in International Prostate Symptom Score (IPSS) over 48 months of treatment. The plot compares three groups: Dutasteride 0.5 mg, Tamsulosin 0.4 mg, and the combination of Dutasteride plus Tamsulosin, each represented by distinct markers. Sample sizes for each group remain consistent throughout the study period.*

FDA Label Image

Figure 2 (Jalyn 04)

A line graph showing mean changes from baseline (mL/sec) on the vertical axis versus months of treatment (0 to 24) on the horizontal axis. It compares three treatments over time: Dutasteride + Tamsulosin, Dutasteride 0.5 mg, and Tamsulosin 0.4 mg, with corresponding sample sizes noted for each treatment group at different time points.*

FDA Label Image

Principal Display Panel (30 Capsule Bottle Label)

Jalyn capsules 0.5 mg / 0.4 mg packaging label showing 30 capsules in a carton. The label includes the proprietary name Jalyn with active ingredients dutasteride and tamsulosin hydrochloride, strength per capsule, and the labeler Waylis Therapeutics. The label also displays a warning about use by women or children, storage instructions, and that the product is made in Germany. The NDC number 80725-809-13 is visible alongside a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.